The published evidence on whether workplace health and well-being interventions are as effective in male-dominated industries compared with mixed-gender environments has not been synthesised. We performed a systematic review of workplace interventions aimed at improving employee health and well-being in male-dominated industries. We searched Web of Knowledge, PubMed, Medline, Cochrane Database and Web of Science for articles describing workplace interventions in male-dominated industries that address employee health and well-being. The primary outcome was to determine the effectiveness of the intervention and the process evaluation (intervention delivery and adherence). To assess the quality of evidence, Cochrane Collaboration’s Risk of Bias Tool was used. Due to the heterogeneity of reported outcomes, meta-analysis was performed for only some outcomes and a narrative synthesis with albatross plots was presented. After full-text screening, 35 studies met the eligibility criteria. Thirty-two studies delivered the intervention face-to-face, while two were delivered via internet and one using postal mail. Intervention adherence ranged from 50% to 97%, dependent on mode of delivery and industry. 17 studies were considered low risk of bias. Albatross plots indicated some evidence of positive associations, particularly for interventions focusing on musculoskeletal disorders. There was little evidence of intervention effect on body mass index and systolic or diastolic blood pressure. Limited to moderate evidence of beneficial effects was found for workplace health and well-being interventions conducted within male-dominated industries. Such interventions in the workplace can be effective, despite a different culture in male-dominated compared with mixed industries, but are dependent on delivery, industry and outcome. CRD42019161283.
|Number of pages||11|
|Journal||Occupational and Environmental Medicine|
|Early online date||25 May 2021|
|Publication status||Published - 13 Jan 2022|
Bibliographical noteFunding Information:
Funding This work is funded by the Wellcome Trust (108902/Z/15/Z). FdV is partly funded by National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust. RCR is a de Pass VC Research Fellow, Vice Chancellor’s Research Fellow at the University of Bristol. This work was supported by Cancer Research UK (C18281/A29019). RCR and RMM are members of the MRC Medical Research Council Integrative Epidemiology Unit at the University of Bristol, supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/5). The work was also supported by Cancer Research UK (C18281/A19169) and the Economic and Social Research Council (ESRC) (ES/N000498/1). RMM is supported by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, which is funded by the NIHR and is a partnership between University Hospitals Bristol NHS Foundation Trust and the University of Bristol.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.